These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
415 related articles for article (PubMed ID: 1967198)
21. [Treatment of Raynaud's syndrome in systemic connective tissue diseases with calcium antagonists]. Shcherbakov AB Vutr Boles; 1988; 27(6):55-8. PubMed ID: 3247706 [TBL] [Abstract][Full Text] [Related]
22. The diagnosis and treatment of Raynaud's phenomenon: a practical approach. Pope JE Drugs; 2007; 67(4):517-25. PubMed ID: 17352512 [TBL] [Abstract][Full Text] [Related]
23. Current management of Raynaud's syndrome. Landry GJ; Edwards JM; Porter JM Adv Surg; 1996; 30():333-47. PubMed ID: 8960343 [TBL] [Abstract][Full Text] [Related]
24. [Thermographic assessment of Raynaud's phenomenon in childhood mixed connective tissue disease]. Yokota S; Kuriyama T; Takahashi Y; Mori M; Shike H; Ibe M; Mitsuda T; Aihara Y Ryumachi; 1994 Dec; 34(6):955-60. PubMed ID: 7863385 [TBL] [Abstract][Full Text] [Related]
25. Raynaud's phenomenon: a review. Cotton LT; Khan O Int Angiol; 1986; 5(4):215-36. PubMed ID: 3585095 [TBL] [Abstract][Full Text] [Related]
26. Recent achievements in the management of Raynaud's phenomenon. Baumhäkel M; Böhm M Vasc Health Risk Manag; 2010 Apr; 6():207-14. PubMed ID: 20407628 [TBL] [Abstract][Full Text] [Related]
27. [Medical treatment of the Raynaud phenomenon]. Zicot M Phlebologie; 1987; 40(1):47-9. PubMed ID: 3033711 [TBL] [Abstract][Full Text] [Related]
29. Clinical inquiries. What is the evaluation and treatment strategy for Raynaud's phenomenon? Tagliarino H; Purdon M; Jamieson B; Hoekzema G J Fam Pract; 2005 Jun; 54(6):553-5. PubMed ID: 15939010 [No Abstract] [Full Text] [Related]
30. [Management of Raynaud's phenomenon]. Lazareth I Ann Dermatol Venereol; 2001 Apr; 128(4):553-6. PubMed ID: 11395659 [No Abstract] [Full Text] [Related]
31. [Raynaud's phenomenon: clinical aspects of the disease]. Konychev AV; Koreshkina TA; Kokorin KV; Kaiukov AV Vestn Khir Im I I Grek; 2001; 160(2):118-22. PubMed ID: 11496483 [No Abstract] [Full Text] [Related]
32. Raynaud's phenomenon. A practical approach to a common problem. Needs J; Laurent R; Manolios N Aust Fam Physician; 1993 Jun; 22(6):1049, 1052-8, 1062-5. PubMed ID: 8338452 [TBL] [Abstract][Full Text] [Related]
33. [The therapy of Raynaud's phenomenon]. Di Giacinto G Clin Ter; 1993 Feb; 142(2):161-74. PubMed ID: 8472530 [TBL] [Abstract][Full Text] [Related]
34. Pharmacological treatment of Raynaud's phenomenon with special reference to calcium-entry blockers. Nilsson H Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():137-49. PubMed ID: 2872769 [TBL] [Abstract][Full Text] [Related]
35. Raynaud's phenomenon in mixed connective tissue disease. Grader-Beck T; Wigley FM Rheum Dis Clin North Am; 2005 Aug; 31(3):465-81, vi. PubMed ID: 16084319 [TBL] [Abstract][Full Text] [Related]
36. [Clinical picture and treatment of the Raynaud syndrome of the upper extremities]. Klüken N; Rabe E Phlebologie; 1987; 40(2):447-54. PubMed ID: 3039544 [TBL] [Abstract][Full Text] [Related]